Close

Biogen Reaches Agreement with Samsung Biologics to Sell Equity Stake in Their Biosimilar Joint Venture for up to $2.3 billion

Go back to Biogen Reaches Agreement with Samsung Biologics to Sell Equity Stake in Their Biosimilar Joint Venture for up to $2.3 billion
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 216.34 --0 (-0%)
Previous Close $216.34    52 Week High $333.65 
Open $216.34    52 Week Low $223.02 
Day High $216.34    P/E 27.70 
Day Low $216.34    EPS $7.81 
Volume 78